mIHC results showed that Abrine co-treated with anti-PD-1 antibody increased CD8+ cytotoxic T cells infiltration in tumor cells, decreased Foxp3+ Treg cells, and inhibited IDO1 and PD-L1 expression (Figure 7D). Here, PDCD1 is linked to neoplasm.